|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 4227 FIFTH AVENUE |
Address2 | 710 ALUMNI HALL |
City | PITTSBURGH |
State | PA |
Zip Code | 15260 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 53356-12
|
||||||||
|
6. House ID# 349820000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Eugenia C. Stoner, Assistant Vice Chancellor, Federal Government Relations |
Date | 07/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
HR 835, S 707, Puppy Uniform Protection and Safety Act: preservation of reasonable, minimal, and appropriate use of animals in biomedical research and their care
HR 1513, S 810, Great Ape Protection and Cost Savings Act of 2011: preservation of reasonable, minimal, and appropriate use of animals in biomedical research and their care
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 1, Full-Year Continuing Appropriations Act, 2011: NIH, NSF, NIST, and Office of Science research funding; student financial aid including Pell Grants and SEOG; funding for the Department of Education's International Studies Centers (Title VI of HEOA); funding for VA health care, prosthetic research, VA research facilities, and veterans' educational benefits; (continued on next page)
HR 1, continued: and research funding for the National Endowment for the Humanities and the National Endowment for the Arts.
HR 1363, Further Additional Continuing Appropriations Amendments, 2011: funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and Performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
HR 1473, Department of Defense and Full-Year Continuing Appropriations Act, 2011: funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
HR 1908, Prioritization of the obligations of the U.S. government: emergency appropriations of funds and prioritization of obligations, if the debt ceiling is reached.
HR 2219, FY2012 Department of Defense Appropriations Act: funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and Performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ECN
16. Specific lobbying issues
S 782, Economic Development Revitalization Act of 2011: reauthorization of the Public Works and Economic Development Act of 1965 in support of regional economic development and infrastructure projects.
HR 1425, S 493, Creating Jobs Through Small Business Innovation Act of 2011, SBIR/STTR Reauthorization Act of 2011: limitation on percentage of SBIR/STTR set-asides for federal departments and agencies, including NIH.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
HR 1249, S 23, Leahy-Smith America Invents Act: advocacy on behalf of patent reform including support for first inventor to file, post-award challenges procedure, and damages provision.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
HR 1363, Further Additional Continuing Appropriations Amendments, 2011: funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and Performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
HR 1473, Department of Defense and Full-Year Continuing Appropriations Act, 2011: funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and Performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
HR 2219, FY2012 Department of Defense Appropriations Act: funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and Performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
HR 1540, National Defense Authorization Act for FY2012: approval of funding for the University of Pittsburgh Drug Discovery Institute (Center for Orphan Disease Drug Discovery); Center for Vaccine Research/Regional Biocontainment Laboratory; Center of Excellence in Biomedical Informatics; Army, Navy, and Air Force Centers for Injury Prevention and Performance Enhancement; and DoD research funding (6.1, 6.2, and 6.3).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 1216, Amendment of the Public Health Service Act to Convert Directly-appropriated Graduate Medical Education (GME) funding to an authorization of appropriations: advocacy in support of GME component of Medicare.
HR 2117, Prohibition on the Department of Education's overreaching into academic affairs and program eligibility under Title IV of the Higher Education Act of 1965: repeal of the state authorization and "credit hour" regulations.
S 1068, Student Loan Simplification and Opportunity Act of 2011: support for temporary student loan debt conversion authority.
S 4039, Campus SaVE Act: amendment of the Higher Education Act of 1965 to improve education and prevention related to campus sexual violence and stalking.
HR 1396, S 588, Marcellus Shale On-the-Job Training Act of 2011: Department of Labor discretionary grants to local areas for adult on-the-job training or dislocated worker on-the-job training at worksites directly related to the exploration for, production of, and transportation of natural gas from the Marcellus Shale formation.
HR 1327, S 705, Collegiate Housing and Infrastructure Act of 2011: support for protection of not-for-profit, tax-exempt status of colleges and universities making payments to collegiate housing organizations for improvement of housing facilities, other than physical education facilities.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
S 847, Safe Chemicals Act of 2011: removal of higher education chemical laboratories from purview of chemical industry environmental and safety standards.
HR 910, S 482, Energy Tax Prevention Act of 2011: support for retention of authority of the EPA administrator to regulate the emission of greenhouse gases to address climate change.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
HR 2146, S 1222, DATA Act: prevention of unnecessary and duplicative federal government data reporting requirements by grant recipients.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
HR 1842, S 952, Development, Relief, and Education for Alien Minors (DREAM) Act of 2011:support for educational purposes of the cancellation of removal and adjustment of status of certain alien students who are long-term U.S. residents and who entered the U.S. as children.
HR 43, Amendment of the Immigration and Nationality Act: support for the retention of the diversity immigrant program and citizenship for immigrants who obtain advanced degrees.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 2, Repealing the Job-Killing Health Care Law Act: support for the retention of the Health Care and Education Reconciliation Act of 2010 and the Patient Protection and Affordable Care Act.
HR 1216, Amendment of the Public Health Service Act to Convert Directly-appropriated Graduate Medical Education (GME) funding to an authorization of appropriations: advocacy in support of direct appropriation for GME component of Medicare.
H.Res. 1219, HR 1217, To Repeal the Prevention and Public Health Fund: support for retention of the establishment of and appropriating funds for the Prevention and Public Health Fund in the Patient Protection and Affordable Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
HR 1425, S 493, Creating Jobs Through Small Business Innovation Act of 2011, SBIR/STTR Reauthorization Act of 2011: limitation on percentage of SBIR/STTR set-asides for federal departments and agencies, including NIH.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 4, S 493, Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011: elimination of Form 1099 reporting requirements for payments of $600 or more in the Patient Protection and Affordable Care Act.
HR 674, Amendment of the Internal Revenue Code of 1986 to repeal the imposition of 3 percent withholding on certain payments made to vendors by government entities: advocacy in support of the bill.
S 557, Public Good IRA Rollover Act of 2011: support for expansion of tax-free distributions from individual retirement accounts for charitable purposes.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPI
16. Specific lobbying issues
H.J.Res. 37, S.J. Res. 6, Joint Resolution of Disapproval of "Net Neutrality" Rules for Internet Service Providers Promulgated by the Federal Communications Commission : support for retention of "net neutrality" regulations.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
HR 1383, S 745, Restoring GI Bill Fairness Act of 2011: preservation of increased level of higher education benefits for veterans at non-public institutions who enrolled before the enactment of the Post-9/11 Veterans Educational Assistance Improvements Act of 2010 (S. 3447).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugenia |
Stoner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |